| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | thymidine | 0.7136 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | thymidine | 0.7564 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | thymidine | 0.8818 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | thymidine | 0.8986 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | thymidine | 0.9651 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | thymidine | 0.966 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | thymidine | 1.034 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | thymidine | 1.072 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | thymidine | 1.1035 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | thymidine | 1.1798 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | thymidine | 1.1821 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | thymidine | 1.4549 | Relative Abundance | GOS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|